RecruitingNCT06449092
The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD
Sponsor
Assiut University
Enrollment
60 participants
Start Date
Jan 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
1. To detect the significance of remenant cholesterol in detection severity of MAFLD 2. To detect the significance of carotid intima-media thickness in MAFLD
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- The study will include adult patients (≥18 years) presented to fibroscan clinic and diagnosed as MAFLD.
Exclusion Criteria4
- Patients Known previous cardiac disease ( cardiovascular disease, heart failure, arrhythmia )
- Patients Known liver cirrhosis
- septic patients
- Patients have malignancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTLipid profile
carotid intima media thickness
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06449092